Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for MCK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
June 30, 2026 394.00M
March 31, 2026 -2.82B
December 31, 2025 -2.026B
September 30, 2025 -961.00M
June 30, 2025 1.176B
March 31, 2025 -2.855B
December 31, 2024 1.298B
September 30, 2024 -1.599B
June 30, 2024 -809.00M
March 31, 2024 -968.00M
December 31, 2023 -622.00M
September 30, 2023 -909.00M
June 30, 2023 -843.00M
March 31, 2023 -1.19B
December 31, 2022 -1.425B
September 30, 2022 -572.00M
June 30, 2022 -1.181B
March 31, 2022 -1.989B
December 31, 2021 -438.00M
September 30, 2021 -1.743B
June 30, 2021 -2.151B
March 31, 2021 -517.00M
December 31, 2020 -775.00M
September 30, 2020 -462.00M
June 30, 2020 61.00M
Date Value
March 31, 2020 -2.48B
December 31, 2019 949.00M
September 30, 2019 -331.00M
June 30, 2019 -872.00M
March 31, 2019 -2.544B
December 31, 2018 119.00M
September 30, 2018 -1.343B
June 30, 2018 1.541B
March 31, 2018 -1.937B
December 31, 2017 125.00M
September 30, 2017 -141.00M
June 30, 2017 -1.131B
March 31, 2017 -924.00M
December 31, 2016 -1.031B
September 30, 2016 -32.00M
June 30, 2016 -82.00M
March 31, 2016 -1.206B
December 31, 2015 -1.057B
September 30, 2015 -987.00M
June 30, 2015 -203.00M
March 31, 2015 -716.00M
December 31, 2014 -84.00M
September 30, 2014 -1.00M
June 30, 2014 -167.00M
March 31, 2014 3.692B

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Cencora, Inc. -1.768B
Cardinal Health, Inc. -487.00M
Henry Schein, Inc. -158.00M
Accendra Health, Inc. -271.98M
CVS Health Corp. -2.693B